Quantcast

Latest Compliance Stories

2014-09-25 08:27:37

University of Toledo's Dr. Sharrel Pinto to Lead Study Using MTS Adherence Packaging Solutions from Omnicell MOUNTAIN VIEW, Calif., Sept. 25, 2014 /PRNewswire/ -- Omnicell® Inc. today announced the commencement of the STOMPP (Study the Effect of a Hybrid Pharmacy Practice Model on Medication Adherence) clinical study. The evaluation is led by Dr. Sharrel Pinto, Division Head and Associate Professor in the Health Outcomes and Socioeconomic Sciences Division and Research Director of the Center...

2014-09-24 23:14:05

Help Doctors, Patients and their Families, Manage Pain and Psych Medications. New Affordable Locked Automatic Pill Dispenser for Home or Institutional Use released by e-pill Medication Reminders. Boston, MA (PRWEB) September 24, 2014 15,000 people die each year from overdosing on prescription painkillers. Addiction to narcotic medication is an epidemic plaguing many patients and their families across the country. Prescription drug abuse is common, 1 in 20 people (12 and older) admitted to...

2014-09-24 16:26:18

JANSSEN® CONNECT® program seeks to provide people living with schizophrenia information and assistance to support healthcare provider-ordered long-acting antipsychotic treatment TITUSVILLE, N.J., Sept. 24, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced the results of a first-of-its-kind study, The Impact of JANSSEN(®) CONNECT(®) Injection Centers on Adherence to an Atypical Long-Acting Injectable Antipsychotic among Patients with Schizophrenia Enrolled in a Support Program....

2014-09-17 12:27:00

Privacy-protected patient support apps now available in Mobile Health Library(TM) for patients prescribed Oxtellar XR® (oxcarbazapine extended-release tablets) and Trokendi XR® (topiramate extended-release capsules) DOYLESTOWN, Pa., Sept. 17, 2014 /PRNewswire/ -- Adherent Health, LLC, a mobile health engagement advisory specializing in medication safe-use, adherence, and health outcomes attainment, announced today the introduction of patient support apps for two novel medications...

2014-09-17 08:29:54

Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens WOONSOCKET, R.I., Sept. 17, 2014 /PRNewswire/ -- An analysis done by the CVS Health Research Institute provides insights regarding patients taking Sovaldi® (sofosbuvir), a new and expensive treatment for Hepatitis C introduced in December. The data shows that over the last several months (May through August 2014) there has been a plateau and actual...

2014-09-17 08:29:46

- Data indicate 58% non-adherence to second-line treatments in T2D patients, significantly higher than patients report and prescribers perceive VIENNA, Sept. 17, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the presentation of compelling, quantitative data from a study of the cost and predictability of non-adherence in type 2 diabetes therapies at the 50(th) Annual Meeting of the European Association for the Study of Diabetes (EASD). In a poster session today, Christian...

2014-09-16 23:03:34

Leadership Shift Supports Drive to Improve Medication Use McLean, Va. (PRWEB) September 16, 2014 RxAnte, the leading platform for improving medication use through predictive analytics and targeted clinical programs, today announced key changes to its management team. The announced changes support the Company’s drive to improve medication effectiveness through the use of predictive analytics and targeted clinical programs. On September 2, 2014, Brock Hardaway, chief executive officer of...

2014-09-15 16:29:14

Patients starting on generic statins vs. branded statins had an eight percent lower rate of cardiovascular events and death WOONSOCKET, R.I., Sept. 15, 2014 /PRNewswire/ -- A new study by researchers at CVS Health (NYSE: CVS) and Brigham and Women's Hospital published today in the Annals of Internal Medicine, is the first to investigate whether starting on a generic versus a brand-name drug for the treatment of high cholesterol is associated with improved health outcomes. The...

2014-09-02 23:03:28

REMIND-A-CAP™ will help the 50% of Americans who do not follow their physician's orders when taking prescription medicine while reducing some of the $290 billion spent each year in avoidable medical expenses attributed to non-adherence New York, NY (PRWEB) September 02, 2014 A New York City based company is focused on addressing the non-adherence epidemic with a simple, yet revolutionary, product that will have far-reaching, positive effects including increasing life span and...

2014-09-02 08:29:40

SAN DIEGO, Sept. 2, 2014 /PRNewswire/ -- Millennium Laboratories has changed its name to Millennium Health, a move that better reflects the company's market position as a broad health solutions company. Through expanded product and service offerings, a robust research and development program, and the acquisition earlier this year of RxAnte, Millennium Health is a leading provider of accurate, timely, clinically actionable information to help tailor patient care. The company is focused...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related